Synthetic lethal kinases in Ras/p53 mutant squamous cell carcinoma
Russell Moser(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Christopher J. Kemp(Fred Hutch Cancer Center), Guangrong Qin(Institute for Systems Biology), Rashmi Joshi(New Mexico State University), Olga Nikolova(Oregon Health & Science University), Ilya Shmulevich(Institute for Systems Biology), Carla Grandori(Precision for Medicine (United States)), Amanda K. Ashley(New Mexico State University), Kay E. Gurley(Fred Hutch Cancer Center), Eduardo Méndez(University of Washington Medical Center)
Cited by 7
Related Papers
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.5k
The Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior
|Annual Review of Cell and Developmental Biology|2000|1.3k
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Personalized <i>In Vitro</i> and <i>In Vivo</i> Cancer Models to Guide Precision Medicine
|Cancer Discovery|2017|964
Direct activation of TERT transcription by c-MYC
|Nature Genetics|1999|903